Cancer Drugs Fund table: 12 drugs delisted, six refused entry
This article was originally published in Scrip
Executive Summary
England's latest Cancer Drugs Fund decisions, which follow a recent overhaul of the assessment process, have resulted in 12 previously funded drugs being withdrawn in 24 indications, and six drugs applying for the first time being refused entry to the fund in seven indications.